Lahaylahay, Feliberto G.

HRN: 15-15-77  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/26/2023
10/03/2023
IV
600mg
Q8H
Infected Wound Left Foot
Waiting Final Action 
09/26/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/26/2023
10/03/2023
IV INFUSION
1.5gm
Q8H
Infected Wound Left Foot
Waiting Final Action 
09/26/2023
MUPIROCIN 2%, 15G (TUBE)
09/26/2023
10/03/2023
TOPICAL
2%
BID
Infected Wound Left Foot
Waiting Final Action 
09/28/2023
CEFTAZIDIME 1GM (VIAL)
09/28/2023
10/05/2023
IV
2grams
Q8HRS
Infected Wound, Left Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: